Pediatric Neurology
Volume 31, Issue 5 , Pages 349-352 , November 2004

Topiramate slow dose titration: Improved efficacy and tolerability

  • Abla M. Albsoul-Younes, PhD

      Affiliations

    • Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
    • Corresponding Author InformationCommunications should be addressed to:Dr. Albsoul-Younes; Chair, Department of Clinical Pharmacy; Faculty of Pharmacy; Jordan University of Science and Technology; P.O. Box 3030; Irbid 22110, Jordan
    • ,
  • Hazem A. Salem, MSc

      Affiliations

    • Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan
    • ,
  • Saleh F. Ajlouni, MD, MRCP

      Affiliations

    • Department of Pediatric Neurology, Royal Medical Center, Amman, Jordan
    • ,
  • Saafan A. Al-Safi, PhD

      Affiliations

    • Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan

Received 27 February 2004 ,Accepted 29 April 2004.

References 

  1. Ormrod D , McClellan K . Topiramate: A review of its use in childhood epilepsy . Pediatr Drugs . 2001;3:293–319
  2. Shorvon SD . The epidemiology and treatment of chronic and refractory epilepsy . Epilepsia . 1996;37(Suppl. 2):S1–3
  3. Marson AG , Kadir ZA , Chadwick DW . New antiepileptic drugs: A systematic review of their efficacy and tolerability . BMJ . 1996;313:1169–1174
  4. White HS , Brown SD , Woodhead JH , Skeen GA , Wolf HH . Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism . Epilepsia . 2000;41(Suppl. 1):S17–20
  5. Jette NJ, Marson AG, Hutton JH. Topiramate add on for drug-resistant partial epilepsy. Cochrane Data Base Syst Rev 2002;CD001417.
  6. Biton V , Montouris GD , Ritter F , et al.  A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures . Neurology . 1999;52:1350–1357
  7. Coppola G , Caliendo G , Terracciano MM , Buono S , Pellegrino L , Pascotto A . Topiramate in refractory partial-onset seizures in children, adolescents and young adults: A multicentric open trial . Epilepsy generalized tonic-clonic seizures. Epilepsy Res . 2001;43:255–260
  8. Nieto-Barrera M , Candau R , Nieto-Jimenez M , Correa A , del Portal LR . Topiramate in the treatment of severe myoclonic epilepsy in infancy . Seizure . 2000;9:590–594
  9. Glauser TA , Clark PO , McGee K . Long-term response to topiramate in patients with West syndrome . Epilepsia . 2000;41(Suppl. 1):S91–4
  10. Ritter F , Glauser TA , Elterman RD , Wyllie E . Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures . Topiramate YP Study Group. Epilepsia . 2000;41(Suppl. 1):S82–5
  11. Mikaeloff Y , de Saint-Martin A , Mancini J , et al.  Topiramate: Efficacy and tolerability in children according to epilepsy syndromes . Epilepsy Res . 2003;53:225–232
  12. Gilliam FG , Veloso F , Bomhof MA , et al.  A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy . Neurology . 2003;60:196–202
  13. Coppola G , Caliendo G , Veggiotti P , et al.  Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: An Italian multicentric study . Epilepsy Res . 2002;51(1-2):147–153
  14. Mohamed K , Appleton R , Rosenbloom L . Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: A clinical experience . Seizure . 2000;9:137–141
  15. Smith AG, Brauer HR, Catalano G, Catalano MC. Topiramate overdose: A case report and literature review. Epilepsy Behav 2001;2:603-7.
  16. Sharief M , Viteri C , Ben-Menachem E , Weber M , Reife R , Karim PR . Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy . Epilepsy Res . 1996;25:217–224
  17. Cross JH . Topiramate monotherapy for childhood absence seizures: An open label pilot study . Seizure . 2002;11:406–410
  18. Elterman RD , Glauser TA , Wyllie E , Reife R , Wu SC , Pledger G . A double blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children . Neurology . 1999;52: 1338-44
  19. Rosenfeld WE , Doose DR , Walker SA , Baldassarre JS , Reife RA . A study of topiramate pharmacokinetics and tolerability in children with epilepsy . Pediatr Neurol . 1999;20:339–344
  20. Korian Topiramate Study GroupLow dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: A multicentre open clinical trial . Seizure . 2002;11:255–260
  21. Levisohn PM . Safety and tolerability of topiramate in children . J Child Neurol . 2000;15(Suppl. 1):S22–6
  22. Dooley JM , Camfield PR , Smith E , Langevin P , Ronen G . Topiramate in intractable childhood onset epilepsy—a cautionary note . Can J Neurol Sci . 1999;26:271–273
  23. Ben-Zeev B , Watemberg N , Augarten A , et al.  Oligohydrosis and hyperthermia: Pilot study of a novel topiramate adverse effect . J Child Neurol . 2003;18:254–257
  24. Kossoff EH , Pyzik PL , Furth SL , Hladky HD , Freeman JM , Vining EP . Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet . Epilepsia . 2002;43:1168–1171
  25. Peeters K , Adriaenssen I , Wapenaar R , Neto W , Pledger G . A pooled analysis of adjunctive topiramate in refractory partial epilepsy . Acta Neurol Scand . 2003;108:9–15

PII: S0887-8994(04)00275-9

doi: 10.1016/j.pediatrneurol.2004.04.012

Pediatric Neurology
Volume 31, Issue 5 , Pages 349-352 , November 2004

Article Tools